(19)
(11) EP 1 056 473 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.07.2005 Bulletin 2005/29

(45) Mention of the grant of the patent:
25.05.2005 Bulletin 2005/21

(21) Application number: 99900624.0

(22) Date of filing: 02.02.1999
(51) International Patent Classification (IPC)7: A61K 41/00
(86) International application number:
PCT/IB1999/000182
(87) International publication number:
WO 1999/039738 (12.08.1999 Gazette 1999/32)

(54)

TARGETED DELIVERY OF BIOLOGICALLY ACTIVE MEDIA

ZIELGERICHTETE ABGABE VON BIOLOGISCHE-AKTIVE MEDIEN

APPORT CIBLE DE MILIEUX BIOLOGIQUEMENT ACTIFS

(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 09.02.1998 EP 98810095

(43) Date of publication of application:
06.12.2000 Bulletin 2000/49

(73) Proprietor: Bracco International B.V.
1077 ZX Amsterdam (NL)

(72) Inventors:
  • SCHNEIDER, Michel
    CH-1256 Troinex (CH)
  • YAN, Feng
    CH-1216 Grand Lancy (CH)
  • HIVER, Agnès
    F-74270 Clarafond (FR)

(74) Representative: Ravizza, Claudio 
Bracco Research SA 31, route de la Galaise
1228 Plan-les-Ouates/Genève
1228 Plan-les-Ouates/Genève (CH)


(56) References cited: : 
WO-A-94/28873
WO-A-95/07072
 WO-A-94/28874
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).